As miR-21 mediates cardiac hypertrophy involving S100a8, which participates in modulating the NF-κB/NFAT pathway, we found that, by suppressing S100a8, miR-21 triggers cardiac hypertrophy under pressure overload. The gene discussed is NFKB1; the disease is cardiac hypertrophy.